The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population

被引:41
作者
Kleibl, Zdenek [1 ]
Havranek, Ondrej [2 ,3 ]
Hlavata, Ivona [4 ,6 ]
Novotny, Jan [3 ,5 ]
Sevcik, Jan [1 ]
Pohlreich, Petr [1 ]
Soucek, Pavel [4 ]
机构
[1] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague 12853 2, Czech Republic
[2] Charles Univ Prague, Dept Med 1, Fac Med 1, Prague 12853 2, Czech Republic
[3] Gen Teaching Hosp, Prague, Czech Republic
[4] Natl Inst Publ Hlth, Lab Toxicogenom, Prague, Czech Republic
[5] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague 12853 2, Czech Republic
[6] Charles Univ Prague, Fac Med 3, Prague 12853 2, Czech Republic
关键词
Checkpoint kinase 2 (CHEK2; CHK2); Colorectal cancer; Germ-line mutation; Genetic screening; Genetic predisposition to disease; Risk assessment; BREAST-CANCER; 1100DELC MUTATION; PROSTATE-CANCER; PROTEIN-KINASE; FHA DOMAIN; CHK2; SUSCEPTIBILITY; VARIANT; BRCA2;
D O I
10.1016/j.ejca.2008.09.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Checkpoint kinase 2 (CHEK2) gene codes for an important mediator of DNA damage response pathway. its mutations increase risk of several types of cancer. We analysed selected CHEK2 mutations in 631 Czech colorectal cancer (CRC) patients. The increased risk of CRC was associated with mutations in CHEK2 gene region involving fork head-associated domain [39/631 (6.2%) cases versus 19/683 (2.8%) controls; odds ratio (OR) = 2.3; 95% confidence interval (CI) = 1.3-4.0; p = 0.003], and with the most frequent I157T mutation [30/631 (4.8%) cases versus 17/683 (2.5%) controls; OR = 2.0; 95% CI = 1.1-3.6; p = 0.03]. Prevalence of 1100delC mutation in CRC patients (4/631) did not differ from that in the control population (2/730; p = 0.4). The deletion of 5395 bp was not found in any of the successfully analysed CRC cases. We observed no association of analysed mutations with CRC family history. We conclude that the I157T and other alterations in its proximity predispose to sporadic but not to familial CRC in the Czech population. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:618 / 624
页数:7
相关论文
共 30 条
[1]   Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain [J].
Ahn, JY ;
Li, XH ;
Davis, HL ;
Canman, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) :19389-19395
[2]   Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[3]   Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers:: case-control study [J].
Brennan, Paul ;
Mckay, James ;
Moore, Lee ;
Zaridze, David ;
Mukeria, Anush ;
Szeszenia-Dabrowska, Neonilia ;
Lissowska, Jolanta ;
Rudnai, Peter ;
Fabianova, Eleonora ;
Mates, Dana ;
Bencko, Vladimir ;
Foretova, Lenka ;
Janout, Vladimir ;
Chow, Wong-Ho ;
Rothman, Nathanial ;
Chabrier, Amelie ;
Gaborieau, Valerie ;
Odefrey, Fabrice ;
Southey, Melissa ;
Hashibe, Mia ;
Hall, Janet ;
Boffetta, Paolo ;
Peto, Julian ;
Peto, Richard ;
Hung, Rayjean J. .
HUMAN MOLECULAR GENETICS, 2007, 16 (15) :1794-1801
[4]   CHEK2 1100delC mutation is frequent among Russian breast cancer patients [J].
Chekmariova, Elena V. ;
Sokolenko, Anna P. ;
Buslov, Konstantin G. ;
Iyevleva, Aglaya G. ;
Ulibina, Yulia M. ;
Rozanov, Maxim E. ;
Mitiushkina, Natalia V. ;
Togo, Alexandr V. ;
Matsko, Dmitry E. ;
Voskresenskiy, Dmitry A. ;
Chagunava, Oleg L. ;
Devilee, Peter ;
Cornelisse, Cees ;
Semiglazov, Vladimir F. ;
Imyanitov, Evgeny N. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) :99-102
[5]  
CHOI DH, 2008, BREAST CANC RES TREA, V112, P159
[6]   CHEK2 is a multiorgan cancer susceptibility gene [J].
Cybulski, C ;
Górski, B ;
Huzarski, T ;
Masojc, B ;
Mierzejewski, M ;
Debniak, T ;
Teodorczyk, U ;
Byrski, T ;
Gronwald, J ;
Matyjasik, J ;
Zlowocka, E ;
Lenner, M ;
Grabowska, E ;
Nej, K ;
Castaneda, J ;
Medrek, K ;
Szymanska, A ;
Szymanska, J ;
Kurzawski, G ;
Suchy, J ;
Oszurek, O ;
Witek, A ;
Narod, SA ;
Lubinski, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (06) :1131-1135
[7]   Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers [J].
Cybulski, Cezary ;
Masojc, Bartlomiej ;
Oszutowska, Dorota ;
Jaworowska, Ewa ;
Grodzki, Tomasz ;
Waloszczyk, Piotr ;
Serwatowski, Piotr ;
Pankowski, Juliusz ;
Huzarski, Tomasz ;
Byrski, Tomasz ;
Gorski, Bohdan ;
Jakubowska, Anna ;
Debniak, Tadeusz ;
Wokolorczyk, Dominika ;
Gronwald, Jacek ;
Tarnowska, Czeslawa ;
Serrano-Fernandez, Pablo ;
Lubinski, Jan ;
Narod, Steven A. .
CARCINOGENESIS, 2008, 29 (04) :762-765
[8]   Epistatic relationship between the cancer susceptibility genes CHEK2 and p27 [J].
Cybulski, Cezary ;
Gliniewicz, Bartlomiej ;
Sikorski, Andrzej ;
Kladny, Jozef ;
Huzarski, Tomasz ;
Gronwald, Jacek ;
Byrski, Tomasz ;
Debniak, Tadeusz ;
Gorski, Bohdan ;
Jakubowska, Anna ;
Wokolorczyk, Dominika ;
Narod, Steven A. ;
Lubinski, Jan .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (03) :572-576
[9]   Germline CHEK2 mutations and colorectal cancer risk:: different effects of a missense and truncating mutations? [J].
Cybulski, Cezary ;
Wokolorczyk, Dominika ;
Kladny, Jozef ;
Kurzwaski, Grzegorz ;
Suchy, Joanna ;
Grabowska, Ewa ;
Gronwald, Jacek ;
Huzarski, Tomasz ;
Byrski, Tomasz ;
Gorski, Bohdan ;
Debniak, Tadeusz ;
Narod, Steven A. ;
Lubinski, Jan .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (02) :237-241
[10]   Mutations in CHEK2 associated with prostate cancer risk [J].
Dong, XY ;
Wang, L ;
Taniguchi, K ;
Wang, XS ;
Cunningham, JM ;
McDonnell, SK ;
Qian, CP ;
Marks, AF ;
Slager, SL ;
Peterson, BJ ;
Smith, BI ;
Cheville, JC ;
Blute, ML ;
Jacobsen, SJ ;
Schaid, DJ ;
Tindall, DJ ;
Thibodeau, SN ;
Liu, WG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) :270-280